Metabolic reprogramming in cancer: dysregulation of glucose, lipid, and amino acid pathways and therapeutic opportunities. - Yu M; Yang D; Chen X; Yang Y; Zhang B; Jiang X; Xing L; Sun Y; Li N (Molecular biomedicine, 2026)